Fresenius Medical Care’s Bold Turnaround: How Care Delivery & Enablement Are Redefining Profitability!

Fresenius Medical Care demonstrated steady progress in its operational and financial performance during the third quarter, reflecting a focused transformation strategy and resilience amid external challenges. The company reported organic revenue growth of 2%, with positive contributions from both Care Delivery and Care Enablement segments. Notably, the U.S. same-market treatment growth turned marginally positive at 0.2%, marking a significant milestone, though still tempered by elevated mortality rates. Internationally, same-market treatment growth accelerated to 3%, supported by strategic portfolio optimization.